SCHEMBL11059686

SCHEMBL11059686

CC(=O)Nc1cc2ncc(C(=O)O)c(O)c2cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 2/20 0.38
EGFR P00533 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
TOP2A P11388 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
ASPH Q12797 1/20 0.36
KDM8 Q8N371 1/20 0.36
CSF1R P07333 5/20 0.35
STK4 Q13043 1/20 0.35
MELK Q14680 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
NUDT1 P36639 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10985618 0.83 MEN1 (0.49) KDM4ECA2STK4ALDH1A1KMT2A
SCHEMBL6197961 0.82 KDM4E (0.43) KDM4EHSD17B10EGFRBRD4BRD2
SCHEMBL9592356 0.77 EGFR (0.45) KDM4EHSD17B10EGFRCA2ASPH
SCHEMBL3871505 0.74 EGFR (0.50) EGFRCSF1RNUDT1
Hydrochloric Acid SCHEMBL6084967 0.73 EGFR (0.49) EGFRCSF1RNUDT1
SCHEMBL10373576 0.72 TP53 (0.36) KDM4EHSD17B10EGFRBRD4BRD2
SCHEMBL1645669 0.71 KIF11 (0.38) KDM4EASPHMELKALDH1A1KMT2A
SCHEMBL8529466 0.71 KDM4E (0.54) KDM4EHSD17B10HDAC1HDAC6CA1
SCHEMBL398640 0.71 DHODH (0.47) ALDH1A1KMT2AMEN1
SCHEMBL5767408 0.71 KEAP1 (0.42) KDM4EHSD17B10CA1CA2CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0134165-A2 7-(Pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid and 7-(pyrrol-1-yl)-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives, their preparation and use as medicaments PROVESAN S.A. (CH) 1985-03-13 EP disclosed